Fortes Pharmaceuticals (01652.HK) announces its interim financial results, with a net loss attributable to shareholders of 23.136 million yuan, representing a 37.37% decrease year-on-year.

Zhtng Cijng APP news, F sn yoy (01652.HK) released its interim performance for the six months ending June 30, 2025, with revenue of 111 million yuan (RMB, the same below), a decrease of 43.31% year-on-year; attributable losses to shareholders were 23.136 million yuan, a decrease of 37.37% year-on-year; basic loss per share was 3 cents.